Oxazole derivatives as histamine H3 receptor agents, preparation and therapeutic uses

Details for Australian Patent Application No. 2005275183 (hide)

Owner Eli Lilly and Company

Inventors Jesudason, Cynthia Darshini; Gadski, Robert Alan; Stevens, Freddie Craig; Hornback, William Joseph; Beavers, Lisa Selsam; Finn, Terry Patrick; Pickard, Richard Todd; Vaught, Grant Matthews; Boulet, Serge Louis

Agent Spruson & Ferguson

Pub. Number AU-B-2005275183

PCT Pub. Number WO2006/019833

Priority 60/591,191 26.07.04 US

Filing date 14 July 2005

Wipo publication date 23 February 2006

Acceptance publication date 17 March 2011

International Classifications

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 277/22 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/019833 Priority application(s): WO2006/019833

17 March 2011 Application Accepted

  Published as AU-B-2005275183

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005275185-A crystalline variable hydrate of (S)-6-(4-(2-((3-(9H-carbazol-4-yloxy)-2hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3pyridinecarbox amide hemisuccinate salt

2005275182-Thienopyridines for treating Hepatitis C